Cancer Therapeutics have expertise in the production, purification and characterisation of recombinant proteins expressed from bacterial, insect and/or mammalian cell lines in quantities appropriate for high throughput screening and structural studies.

All proteins are characterised by mass spectrometry, N-terminal sequencing, thermal denaturation curves and dynamic light scattering to ensure consistent quality.

To date, more than 100 proteins have been produced successfully for Cancer Therapeutics projects.

_DSC6520